Peripheral lymphocyte subsets vary with stage of hepatitis C virus-associated liver disease

Hepato-Gastroenterology

Volumn 52, Issue 66, 2005, Pages 1803-1808

  Morita, Kiyoshi ^a   Fukuda, Yoshihide ^a   Nakano, Isao ^a   Katano, Yoshiaki ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD5+ B cell; Hepatitis C virus; Lymphocyte subset; T helper profile, t cell

Indexed keywords

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER DISEASE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; TH2 CELL;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 28544443925     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al: The natural history of community-acquired hepatitis C in the United States. New Engl J Med 1992; 327:1899-1905.
2. Iwarson S, Norkran G, Wejstal R: Hepatitis C: natural history of a unique infection. Clin Infect Dis 1995; 20:1361-1370.
3. Corado J, Toro F, Rivera H, Bianco NE, Deibis L, De Sanctis JB: Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 1997; 109:451-457.
4. Sansonno D, Cornacchiulo V, Iacobelli AR, Gatti P, Distasi M, Dammacco F: Hepatitis C virus infection and clonal B cell expansion. Clin Exp Rheumatol 1996; 14(Suppl):S45-50.
5. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, et al: T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104:580-587.
6. Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, et al: Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21:632-638.
7. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, et al: Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999; 96:5692-5697.
8. Napoli J, Bishop A, Mc Guinness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24:759-765.
9. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC: Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25:449-458.
10. Jung T, Schauer U, Hesser C, Neumann C, Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Method 1993; 159:197-207.
11. Nakano I, Fukuda Y, Katano Y, Kohsaka T, Miyazaki T, Hayakawa T: Characteristic changes of peripheral lymphocyte subset in cirrhotic patients with hepatitis C virus-correlation with cirrhotic severity. Hepatol Res 1999; 15:43-51.
12. Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, et al: Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: implications for vaccine development. Hepatology 1999; 30:1088-1098.
13. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al: Recurrence of hepatitis C virus after loss of virus-specific CD4+ T cell response in acute hepatitis C. Gastroenterology 1999; 117:933-941.
14. Keeffe EB, Iwarson S, MaMahon BJ, Lindsay KL, Koff RS, Manns M, et al: Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27:881-886.
15. Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, et al: Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000; 31:230-234.
16. Schirren CA, Jung MC, Zachoval R, Diepolder H, Hoffmann R, Riethmuller G, Pape GR: Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other cell-dependent functions. Clin Exp Immunol 1997; 108:144-150.
17. Shiratori Y, Yokosuka O, Nakata R, Ihori M, Hirota K, Katamoto T, et al: Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA. Hepatology 1999; 29:1573-1580.
18. Salerno A, Dieli F: Role of gamma delta T lymphocytes in immune response in humans and mice. Crit Rev Immunol 1998; 18:327-357.
19. Boismenu R, Havran WL: Gamma delta T cells in host defense and epithelial cell biology. Clin Immunol Immunopathol 1998; 86:121-133.
20. Agnello V: The etiology anf pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19:111-129.
21. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, et al: Different cytokine profiles of intrahepatic T cells in Chronic hepatitis B and hepatitis C infections. Gastroenterology 1997; 112:193-199.
22. Kawakami Y, Nabeshima S, Furusho N, Sawayama Y, Hayashi J, Kashiwagi S: Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95:227-232.
23. Kimura K, Ando K, Tomita E, Ohnishi H, Ishikawa T, Kakumu S, et al: Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fluminant hepatitis. J Hepatol 1999; 31:579-583.
24. Norris S, Collons C, Doherty DG, Smith F, McEntee G, Traynor O, et al: Resident human lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998; 28:84-90.
25. Winnock M, Garcia Barcina M, Lukomska B, Huet S, Saric J, Balabaud C, Bioulac-Sage P: Human liver-associated lymphocytes: an overview. J Gastroenterol Hepatol 1995; 10(Suppl 1):S43-46.
26. Tran A, Yang G, Doglio A, Ticchioni M, Laffont C, Durant J, et al: Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C. Dig Dis Sci 1997; 42:2495-2500.